CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −399 | $537.40 | $214K | 49,614 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −401 | $538.43 | $216K | 49,213 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −535 | $539.24 | $288K | 48,678 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,154 | $540.46 | $1.7M | 45,524 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,671 | $541.23 | $904K | 43,853 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,797 | $542.40 | $975K | 42,056 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −240 | $543.03 | $130K | 41,816 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −560 | $544.45 | $305K | 41,256 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −743 | $545.71 | $405K | 40,513 |
| 2026-06-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 40,910 | ||
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $117.76 | $1.2M | 28,876 |
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −46 | $542.94 | $25K | 28,830 |
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −154 | $544.37 | $84K | 28,676 |
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −442 | $545.14 | $241K | 28,234 |
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −134 | $547.08 | $73K | 28,100 |
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,037 | $548.02 | $1.1M | 26,063 |
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,974 | $549.11 | $1.1M | 24,089 |
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,333 | $550.04 | $1.8M | 20,756 |
| 2026-06-11 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,560 | $551.10 | $860K | 19,196 |
Page 84 of 120 · 2,391 trades